Arkolith/Insider Trading/CHRS/Form 4

McMichael Bryan J

Chief Financial OfficerCoherus Oncology, Inc. (CHRS) · full profile →Form 4 · filed Jun 3, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
12
0 non-derivative · 12 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
May 29, 2026Disposed to issuer(D)100K——0
May 29, 2026Disposed to issuer(D)25K——0
May 29, 2026Disposed to issuer(D)15K——0
May 29, 2026Disposed to issuer(D)25K——0
May 29, 2026Disposed to issuer(D)25K——0
May 29, 2026Disposed to issuer(D)30K——0
May 29, 2026Grant(A)100K——100K
May 29, 2026Grant(A)25K——25K
May 29, 2026Grant(A)15K——15K
May 29, 2026Grant(A)25K——25K
May 29, 2026Grant(A)25K——25K
May 29, 2026Grant(A)30K——30K

Transaction Codes

D
Disposition to the issuer
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-26-069622) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML